• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.12% Nasdaq Up0.71%

    WuXi PharmaTech (Cayman) Inc. (WX)

    39.62 Up 0.26(0.66%) Apr 24, 4:02PM EDT
    Add to Portfolio
    ProfileGet Profile for:
    WuXi PharmaTech (Cayman) Inc.
    288 Fute Zhong Road
    China (Shanghai) Pilot Free Trade Zone
    Shanghai, 200131
    China - Map
    Phone: 86 21 5046 1111
    Website: http://www.wuxiapptec.com

    Index Membership:N/A
    Industry:Medical Laboratories & Research
    Full Time Employees:8,837

    Business Summary 

    Wuxi PharmaTech (Cayman) Inc. operates as a pharmaceutical, biotechnology, and medical device research and development services company in China and the United States. It operates through two segments, Laboratory Services and Manufacturing Services. The Laboratory Services segment offers services for small molecules, such as synthetic chemistry, biology, medicinal chemistry, DMPK/ADME, formulation, analytical chemistry, toxicology, clinical development, bioanalytical, genomics, bioinformatics, research reagent production, and clinical services; services for discovery and development of biologics; and laboratory services, including testing services for biologics, medical devices, and combination products, as well as production of cell therapies. The Manufacturing Services segment provides manufacturing services, including development of manufacturing processes; and the production of advanced intermediates and active pharmaceutical ingredients for use by pharmaceutical companies in preclinical and clinical trials of small-molecule products, and in commercial products, as well as the production of biologic products. The company sells its products to pharmaceutical, biotechnology, and medical device companies, as well as academic institutions and non-profit organizations. Wuxi PharmaTech (Cayman) Inc. was founded in 2000 and is headquartered in Shanghai, China.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on WuXi PharmaTech (Cayman) Inc.

    Key Executives 
    Dr. Ge Li Ph.D., 48
    Co-Founder, Chairman, Chief Exec. Officer, Member of Strategy & Fin. Committee and Member of Corp. Governance & Nominations Committee
    Mr. Xiaozhong Liu , 51
    Founder, Exec. VP and Director
    Dr. Ning Zhao Ph.D., 48
    Co-Founder, Sr. VP of Operations, Head of Corp. HR and Director
    Mr. Zhaohui Zhang , 45
    Founder, Head of Domestic Marketing, Sr. VP of Operations and Director
    Mr. Edward Hu M.B.A., 52
    Chief Financial Officer and Chief Investment Officer
    Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.